Provectus Pharmaceuticals
About:
Provectus Pharmaceuticals develops advanced therapies that destroy cancers such as melanoma, liver, and breast cancer.
Website: http://pvct.com
Description:
Provectus Pharmaceuticals focuses on creating sophisticated medicines to target and eliminate the most lethal cancers. Provectus also creates ground-breaking biotechnologies to improve vaccine production and detect viruses. It develops and markets innovative over-the-counter skin care products, as well as licensing unique technologies for therapeutic and cosmetic medical devices.
Total Funding Amount:
$10.6M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Knoxville, Tennessee, United States
Founded Date:
1978-05-01
Contact Email:
info(AT)pvct.com
Founders:
Craig Dees
Number of Employees:
51-100
Last Funding Date:
2014-04-17
IPO Status:
Public
Industries:
© 2025 bioDAO.ai